Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.
University of California San Diego researchers describe how a pair of fundamental genetic and cellular processes — aneuploidy and unfolded protein response — are exploited by cancer cells to promote tumor survival and growth.
Spin, a micromobility provider, and TransLoc, a transportation software solutions company, are combining efforts to deliver and integrate sustainable transportation modes, improving how the university’s 75,000 students, faculty and staff move around campus.